ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,129.21
0.55%
Dow Jones
43,600.80
0.44%
Gold vs US Dollar
2,669.25
0.63%
Brent Oil
73.675
1.15%
Bitcoin
96,419.02
2.18%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Catabasis Pharmaceuticals Inc (CATB)

  7. Catabasis Pharmaceuticals Inc (CATB) News

Catabasis Pharmaceuticals (CATB)

Catabasis Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:CATB
DateTimeSourceHeadlineSymbolCompany
06/06/202312:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CATBCatabasis Pharmaceuticals Inc
06/06/202312:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CATBCatabasis Pharmaceuticals Inc
06/06/202312:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CATBCatabasis Pharmaceuticals Inc
06/06/202312:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CATBCatabasis Pharmaceuticals Inc
06/06/202312:07Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CATBCatabasis Pharmaceuticals Inc
06/06/202312:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CATBCatabasis Pharmaceuticals Inc
06/06/202312:05Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CATBCatabasis Pharmaceuticals Inc
24/05/202310:02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:CATBCatabasis Pharmaceuticals Inc
11/05/202320:11Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CATBCatabasis Pharmaceuticals Inc
20/04/202320:05Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:CATBCatabasis Pharmaceuticals Inc
20/04/202320:04Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
19/04/202312:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CATBCatabasis Pharmaceuticals Inc
19/04/202312:09Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:CATBCatabasis Pharmaceuticals Inc
06/04/202320:01Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
31/03/202312:00Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CATBCatabasis Pharmaceuticals Inc
22/03/202312:09Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CATBCatabasis Pharmaceuticals Inc
14/02/202320:46Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
14/02/202320:04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
14/02/202313:28Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
14/02/202311:02Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
10/01/202317:49Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CATBCatabasis Pharmaceuticals Inc
05/01/202313:01Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CATBCatabasis Pharmaceuticals Inc
22/12/202221:03Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CATBCatabasis Pharmaceuticals Inc
21/12/202221:31Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:CATBCatabasis Pharmaceuticals Inc
21/12/202219:13Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CATBCatabasis Pharmaceuticals Inc
15/12/202222:17Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CATBCatabasis Pharmaceuticals Inc
15/12/202211:35Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CATBCatabasis Pharmaceuticals Inc
10/11/202221:15Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CATBCatabasis Pharmaceuticals Inc
10/11/202221:06Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CATBCatabasis Pharmaceuticals Inc
10/11/202221:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CATBCatabasis Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:CATB

Your Recent History

LSE
DEC
Diversified Energy
LSE
VAST
Vast Resources
LSE
POS
Plexus
LSE
SYME
Supply@me Capital
LSE
MIN
Minoan
LSE
LIO
Liontrust Asset Management
LSE
STX
Shield Therapeutics
LSE
AAZ
Anglo Asian Mining
LSE
ITM
Itm Power
LSE
GGP
Greatland Gold
LSE
NEXN
Nexxen
LSE
TERN
Tern
LSE
LLOY
Lloyds Banking
LSE
BOO
Boohoo
LSE
THG
Thg
LSE
TW.
Taylor Wimpey
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Level 2 Lite

    1 year 40%, 2 years 50% and *3 years 60%
    EU Flag

    *Across 3 years £2132.64 only £853.06